MULTIVITAMINES SÉNIOR
Food supplement declared in France, declaration No 2024-5-1371, decision dated 27 May 2024
MULTIVITAMINES SÉNIOR (CARÉLINK) is a food supplement declared in France. Status: declared in France, may be marketed. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- CARÉLINK
- Food business operator placing the product on the market
- H2V LABORATOIRE
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Tablet
- Daily dose
- 1 à 2 compriméS
- Directions for use
- 1 à 2 comprimés par jour, avec un grand verre d’eau, en cure de 30 jours plusieurs fois par an.
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Taking anticoagulants, Taking antidepressants, Prolonged use
- Objectives stated by the manufacturer (these are not authorised claims)
- Antioxidant, Arteries and cholesterol, Joints, Hair and nails, Blood and lymphatic circulation, Growth and development, Memory, Eye / Vision, Bones
Declaration 142083, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Bacopa monnieri (L.) Wettst. | Parties aériennes | Extrait sec hydroalcoolique | 250 mg |
| Ginkgo biloba L. | Feuille | Extrait sec hydroalcoolique | 50 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Lutéine | not declared |
| Zéaxanthine | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| D-pantothénate de calcium | Acide pantothénique (vitamine B5) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| D-biotine | Biotine (vitamine B8) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| Béta-carotène | Bêta-carotène | pas de limite (données insuffisantes) | no fixed dose |
| Gluconate de cuivre | Cuivre | 5,000 µg | 2,000 µg |
| Gluconate ferreux | Fer | 40 mg (safe level) | 14 mg |
| Acide ptéroylmonoglutamique | Folates (vitamine B9) | 1,000 µg | 200 µg |
| Oxyde de magnésium | Magnésium | 250 mg | 300 mg |
| Gluconate de manganèse | Manganèse | 8 mg (safe level) | 3.5 mg |
| Nicotinamide | Nicotinamide (vitamine B3) | 900 mg | 54 mg |
| Levure enrichie en sélénium | Sélénium | 255 µg | 50 µg |
| Chlorhydrate de thiamine | Vitamine B1 (thiamine) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| Cyanocobalamine | Vitamine B12 | pas d'effet indésirable défini | dose annulled by the French Council of State in 2011 |
| Riboflavine | Vitamine B2 (riboflavine) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| Chlorhydrate de pyridoxine | Vitamine B6 | 12 mg | 2 mg |
| Acide L-ascorbique | Vitamine C | pas de limite (données insuffisantes) | 180 mg |
| Cholécalciférol | Vitamine D | 100 µg (4,000 UI) | 5 µg (200 UI) |
| Acétate de DL-alpha-tocophéryle | Vitamine E | 300 mg | 30 mg |
| Gluconate de zinc | Zinc | 25 mg | 15 mg |
Additives
E570, E460, Hydroxypropyl Méthyl Cellulose, E470b
Other ingredients
maltodextrine
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Contient du bêta-carotène. Déconseillé aux fumeurs et aux personnes souffrant de maladies ayant pour conséquence une accumulation anormale de fer (hémochromatose, polyglobulie...). Déconseillé aux personnes sous traitements anti-dépresseur et anti-coagulant. Déconseillé en usage prolongé.
Regulatory points
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Ginkgo biloba L.
Read the warning, when it applies and the studies cited
GINKGO - GINKGO BILOBA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).
Sources cited by Health Canada (3)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
- WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
- OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Contraindications
Do not use if you are having a surgery (Gardner and McGuffin 2013).
Sources cited by Health Canada (1)
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).
Sources cited by Health Canada (3)
- Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Systematic review
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- MULTIVITAMINES SENIOR Love&Diet, declared in 2025 : different composition: 2 ingredient(s) added, 6 missing
- Multivitamines Sénior ADP NUTRITION, declared in 2022 : same declared composition
- Multivitamines senior VITAVEA - Laboratoires Nutrisanté, declared in 2022 : different composition: 9 ingredient(s) added, 15 missing
- Multivitamines sénior Nutrisanté, declared in 2021, earlier declaration, replaced by the 2022 declaration : different composition: 11 ingredient(s) added, 14 missing
Brand : CARÉLINK
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.